LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 41.84 | 84.90 | 1865 | 4003 | 0.4659 | 0.7433 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.55 | 84.90 | 156 | 4287 | 0.0364 | 0.1135 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.55 | 84.90 | 1735 | 4287 | 0.4046 | 0.7045 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.55 | 84.90 | 1579 | 4287 | 0.3682 | 0.6763 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 43.55 | 84.90 | 1923 | 4287 | 0.4485 | 0.7357 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.25 | 84.90 | 180 | 4539 | 0.0396 | 0.1399 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.25 | 84.90 | 1823 | 4539 | 0.4016 | 0.7061 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.25 | 84.90 | 1849 | 4539 | 0.4073 | 0.7103 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 45.25 | 84.90 | 2027 | 4539 | 0.4465 | 0.7379 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.95 | 84.90 | 186 | 4952 | 0.0376 | 0.1431 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.95 | 84.90 | 1875 | 4952 | 0.3786 | 0.6948 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.95 | 84.90 | 1901 | 4952 | 0.3838 | 0.6988 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 46.95 | 84.90 | 2079 | 4952 | 0.4198 | 0.7249 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.65 | 84.90 | 184 | 5328 | 0.0345 | 0.1383 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.65 | 84.90 | 1965 | 5328 | 0.3688 | 0.6923 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.65 | 84.90 | 1984 | 5328 | 0.3723 | 0.6950 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 48.65 | 84.90 | 2173 | 5328 | 0.4078 | 0.7211 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.36 | 84.90 | 205 | 5651 | 0.0363 | 0.1567 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.36 | 84.90 | 2060 | 5651 | 0.3645 | 0.6931 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.36 | 84.90 | 2087 | 5651 | 0.3693 | 0.6967 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 50.36 | 84.90 | 2261 | 5651 | 0.4001 | 0.7193 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 52.06 | 84.90 | 233 | 5990 | 0.0389 | 0.1787 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 52.06 | 84.90 | 2118 | 5990 | 0.3535 | 0.6885 | MN20160318_Q02 | D16 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 52.06 | 84.90 | 2177 | 5990 | 0.3634 | 0.6961 | MN20160318_Q02 | K11 |
| MCF 10A-H2B-mCherry | Dasatinib | 1 | 52.06 | 84.90 | 2352 | 5990 | 0.3926 | 0.7175 | MN20160318_Q02 | K11 |